This study was funded by Bayer Biologics Canada.
Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score
Version of Record online: 11 NOV 2005
Volume 46, Issue 1, pages 80–89, January 2006
How to Cite
Cooper, A. B., Cohn, S. M., Zhang, H. S., Hanna, K., Stewart, T. E., Slutsky, A. S. and the ALBUR Investigators (2006), Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion, 46: 80–89. doi: 10.1111/j.1537-2995.2005.00667.x
- Issue online: 22 DEC 2005
- Version of Record online: 11 NOV 2005
- Received for publication December 7, 2004; revision received June 7, 2005, and accepted June 10, 2005.
BACKGROUND: The effect of 5 percent human albumin on multiple organ dysfunction was investigated during the first 14 days of treatment to determine whether albumin resuscitation might benefit adult burn patients.
STUDY DESIGN AND METHODS: Multicenter unblinded controlled trial with stratified block (two patients per block) randomization by center and mortality prediction at enrollment (high-risk stratum [predicted mortality, 50%-90%] and low-risk stratum [predicted mortality, <50%]). The primary outcome was the worst multiple organ dysfunction score (MODS), excluding the cardiovascular component, to Day 14. Eligible adults (>15 years) suffering from thermal injury not more than 12 hours before enrollment received fluid resuscitation with Ringer's lactate (n = 23) or 5 percent human albumin plus Ringer's lactate (n = 19) by protocol to achieve recommended (American Burn Association) resuscitation endpoints.
RESULTS: Forty-two patients were randomly assigned. There were no significant differences (median [95% confidence intervals]) in age (36 [24-45] vs. 31 [25-39] years), burn size (39 [32-53] vs. 32 [26-34] total body surface area percentage), inhalation injury (n = 12/19 vs. n = 11/23), or baseline MODS (3 [1-5] vs. 1.5 [0-2]) between the treatment and control groups. In an intention-to-treat analysis, there was no significant difference between the treatment and control group in the lowest MODS from Day 0 to Day 14 (analysis of covariance, p = 0.73).
CONCLUSION: Treatment with 5 percent albumin from Day 0 to Day 14 does not decrease the burden of MODS in adult burn patients.